Release Date: August 28, 2018
Expiration date: February 28, 2019
Estimated Time to Complete Activity: 25 minutes
CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
CME for MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
OVERVIEW
The expanding indications for use of TAVR in additional patient populations present new and exciting challenges for the interventionalist. This webcast will focus on indications for intermediate risk TAVR patients and emerging clinical evidence from major TAVR trials. Discussion is also provided surrounding TAVR in lower-risk patients and the current appropriate uses for surgical valve replacement given the shifting context of TAVR indications.
LEARNING OBJECTIVES
By the end of this program, participants should be able to:
1) Discuss the expanding breadth of indications for transcatheter valve therapies
2) Explain the impact recent indication changes for intermediate risk patients may have on the TAVR patient population
3) Assess the likelihood for TAVR indications expanding to lower-risk patients and the potential clinical outcomes
TARGET AUDIENCE
This educational activity is designed for interventional cardiologists, clinical cardiologists, and other healthcare professionals involved
in the management of patients with valvular heart disease.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the course directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.
FACULTY DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E) Equity (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Jeffrey J. Popma: (G/R) Medtronic, Abbott Vascular, (G/R) (C/H/S) Boston Scientific, Edwards Lifesciences
Christopher U. Meduri: (C/H/S)Medtronic, Boston Scientific, Trialign National, Intrepid Steering
Vinod H. Thourani: (G/R) (C/H/S)Boston Scientific, Cryolife, Edwards Lifesciences, (C/H/S) Abbott Vascular, WL Gore
PLANNING COMMITTEE
Robert Blanco (Planner)
(S) Cardiovascular Research Foundation
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation and supported through an educational grant from Medtronic. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Robert Blanco at rblanco@crf.org .